These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29760258)

  • 21. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study.
    Smeets CHW; Zuidema SU; Hulshof TA; Smalbrugge M; Gerritsen DL; Koopmans RTCM; Luijendijk HJ
    J Clin Epidemiol; 2018 Sep; 101():17-27. PubMed ID: 29782995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

  • 25. Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
    Mu X; Takeuchi H
    J Clin Psychiatry; 2024 Mar; 85(2):. PubMed ID: 38518288
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical inquiry: how best to treat agitation in patients with irreversible dementia?
    Beck S; Ludwig MJ; Safranek S
    J Fam Pract; 2013 Jul; 62(7):377-87. PubMed ID: 23957033
    [No Abstract]   [Full Text] [Related]  

  • 27. Involving the resident/decision maker in antipsychotic medication use.
    Mort JR
    S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
    Mintzer JE
    J Clin Psychiatry; 2006; 67 Suppl 10():3-5. PubMed ID: 16965189
    [No Abstract]   [Full Text] [Related]  

  • 29. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
    Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of disturbed behavior in patients with dementia].
    van de Boogerd ME; Pisters-van Roy AA; Wiertz YD
    Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1419-20. PubMed ID: 1353612
    [No Abstract]   [Full Text] [Related]  

  • 31. An unsubstantiated conclusion.
    Reifler BV; Blazer D
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.
    Okumura Y; Togo T; Fujita J
    Int Psychogeriatr; 2015 Mar; 27(3):407-15. PubMed ID: 25213318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroleptics in geriatric psychiatry].
    Cohen A
    Soins Gerontol; 2014; (105):7. PubMed ID: 24600944
    [No Abstract]   [Full Text] [Related]  

  • 34. [Withdrawal versus continuation of antipsychotic drugs in people with dementia].
    Lolk A
    Ugeskr Laeger; 2014 Jul; 176(31):. PubMed ID: 25292325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the agitated patient. A pharmacological update.
    McGough JJ; Bona JR
    N C Med J; 1988 Oct; 49(10):497-9. PubMed ID: 2903452
    [No Abstract]   [Full Text] [Related]  

  • 36. Can decreasing antipsychotic use lead to growth in mental and emotional health?
    Bueckert V
    Alta RN; 2014; 70(2):12-4. PubMed ID: 25137891
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to Bogaiksy's letter to the editor.
    Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
    [No Abstract]   [Full Text] [Related]  

  • 38. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Bogaisky M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
    Lin YT; Hwang TJ; Shan JC; Chiang HL; Sheu YH; Hwu HG
    J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citalopram in agitated and delusional demented patients who failed treatment with antipsychotic agents.
    Kotbi N; Singh A; Kneifati-Hayek J; Odom A; Alexopoulos G
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E62. PubMed ID: 24763800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.